PORTAGE, Mich.--(BUSINESS WIRE)-- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Incompass® ...
The U.S. Food and Drug Administration on Monday issued a safety advisory on Stryker's Scandinavian Total Ankle Replacement, or STAR Ankle, devices, citing the risk of a plastic component breaking ...
The U.S. Food and Drug Administration (FDA) is warning patients and healthcare providers of a “higher than expected risk” of failure in Stryker Scandinavian Total Ankle Replacement (STAR) devices.
Stryker SYK recently received FDA clearance for its InCompass Total Ankle System, marking a pivotal expansion in the company's Foot & Ankle portfolio. Designed to address end-stage ankle arthritis, ...
Stryker Corporation (Kalamazoo, MI) has announced a definitive agreement to acquire assets from Small Bone Innovations Inc. (Sbi), a privately held company headquartered in Morrisville, PA, in an ...
PORTAGE, Mich.--(BUSINESS WIRE)-- Stryker (NYSE:SYK), a global leader in medical technologies, will launch its Incompass™ Total Ankle System at the 2025 American Orthopaedic Foot & Ankle Society ...